Baroreflex activation therapy in heart failure patients with reduced ejection fraction: a long-term follow up

被引：0
作者：
Wang, D. [1 ]
Mueller-Leisse, J. [1 ]
Hillmann, H. A. K. [1 ]
Eiringhaus, J. [1 ]
Berliner, D. [1 ]
Karfoul, N. [1 ]
Schmitto, J. D. [2 ]
Ruhparwar, A. [2 ]
Bauersachs, J. [1 ]
Duncker, D. [1 ]
机构：
[1] Hannover Med Sch, Cardiol & Angiol, Hannover, Germany
[2] Hannover Med Sch, Cardiothorac Transplantat & Vasc Surg, Hannover, Germany
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.1141
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction
    Gronda, Edoardo
    Francis, Darrel
    Zannad, Faiez
    Hamm, Christian
    Brugada, Josep
    Vanoli, Emilio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2017, 18 (09) : 641 - 649
  • [22] Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective
    Halbach M.
    Fritz T.
    Madershahian N.
    Pfister R.
    Reuter H.
    Current Heart Failure Reports, 2016, 13 (2) : 71 - 76
  • [23] Long-term follow-up on the morbidity and mortality of patients hospitalized for heart failure with a normal ejection fraction
    Klapholz, M
    Varshneya, N
    Hermandez, E
    Voleti, R
    Bhargava, S
    Kudithipudi, V
    Taik, Z
    Gupta, R
    Ratnasiri, G
    Sehhat, K
    Hanah, M
    Ambrose, JA
    Burcham, J
    LeJemtel, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 184A - 185A
  • [24] LONG-TERM FOLLOW-UP OF REDUCED EJECTION FRACTION HEART FAILURE PATIENTS RECEIVING AUTONOMIC REGULATION THERAPY IN THE ANTHEM-HF PILOT STUDY
    Premchand, Rajendra K.
    Sharma, Kamal
    Mittal, Sanjay
    Monteiro, Rufino
    Libbus, Imad
    DiCarlo, Lorenzo
    Ardell, Jeffrey
    Amurthur, Badri
    Kenknight, Bruce
    Anand, Inderjit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 770 - 770
  • [25] Baroreflex Activation Therapy for Patients With Heart Failure and Low Ejection Fraction is Safe and Effective
    Ad, Niv
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2016, 28 (02) : 329 - 330
  • [26] Long-term Follow-Up of Patients with Heart Failure and Reduced Ejection Fraction Receiving Autonomic Regulation Therapy in the ANTHEM-HF Pilot Study
    Sharma, Kamal
    Premchand, Rajendra K.
    Mittal, Sanjay
    Monteiro, Rufino
    Libbus, Imad
    DiCarlo, Lorenzo A.
    Ardell, Jeffrey L.
    Amurthur, Badri
    KenKnight, Bruce H.
    Anand, Inder S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 323 : 175 - 178
  • [27] Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy
    Zile, Michael R.
    Abraham, William T.
    Weaver, Fred A.
    Butter, Christian
    Ducharme, Anique
    Halbach, Marcel
    Klug, Didier
    Lovett, Eric G.
    Mueller-Ehmsen, Jochen
    Schafer, Jill E.
    Senni, Michele
    Swarup, Vijay
    Wachter, Rolf
    Little, William C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (10) : 1066 - 1074
  • [28] Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study
    Kontogeorgos, Silvana
    Thunstrom, Erik
    Johansson, Magnus C.
    Fu, Michael
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 232 : 86 - 92
  • [29] Baroreflex activation therapy in heart failure with reduced ejection fraction improves cardiopulmonary function during exercise
    Nottebohm, P.
    Dumitrescu, D.
    Madershahian, N.
    Baldus, S.
    Reuter, H.
    Halbach, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 482 - 482
  • [30] Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction
    Halbach, M.
    Fritz, T.
    Madershahia, N.
    Pfister, R.
    Reuter, H.
    HERZ, 2015, 40 (07) : 959 - 965
12345